Nipah virus outbreaks in Kerala
The Nipah virus outbreaks in Kerala refer to the series of epidemic occurrences of the Nipah virus infection in the southern Indian state of Kerala. The first outbreak was reported in 2018, followed by another in 2019. The Nipah virus is a zoonotic virus, transmitted to humans from animals, and can also be transmitted through contaminated food or directly between people.
History[edit]
The first outbreak was reported in May 2018 in the district of Kozhikode. The virus claimed 17 lives and infected 18 people. The second outbreak occurred in June 2019 in the district of Ernakulam, with one confirmed case and one death.
Transmission and Symptoms[edit]
The Nipah virus is primarily transmitted to humans from fruit bats, specifically the Indian Flying Fox. The virus can also be transmitted through contaminated food or directly between people. Symptoms of the Nipah virus infection include fever, headache, drowsiness, disorientation, mental confusion, and potentially fatal encephalitis and myocarditis.
Prevention and Control[edit]
Prevention and control measures for the Nipah virus include avoiding exposure to sick pigs and bats in endemic areas, and not drinking raw date palm sap. In the event of an outbreak, standard infection control practices and proper barrier nursing techniques are crucial in preventing hospital-acquired infections.
See Also[edit]
|
<img src="
This India-health related article is a stub. You can help WikiMD by expanding it. |
-
Nipah virus from an infected VERO cell
-
Lini Puthussery
-
Nipah outbreak 2021 Kozhikode - 3 kilometers buffer zone map around the epicentre
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian